Medical professional network Doximity (NYSE: DOCS) will be reporting earnings this Thursday after the bell. Here’s what to look for.
Doximity beat analysts’ revenue expectations by 7.2% last quarter, reporting revenues of $168.5 million, up 23.2% year on year. It was a strong quarter for the company, with a solid beat of analysts’ EBITDA estimates and an impressive beat of analysts’ revenue estimates.
Is Doximity a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, analysts are expecting Doximity’s revenue to grow 7.6% year on year to $181.5 million, slowing from the 24.6% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.45 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Doximity has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 5.3% on average.
Looking at Doximity’s peers in the vertical software segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Dolby Laboratories’s revenues decreased 2.9% year on year, beating analysts’ expectations by 4.4%, and Agilysys reported revenues up 15.6%, topping estimates by 1.4%. Dolby Laboratories traded up 1.8% following the results while Agilysys was down 20%.
Read our full analysis of Dolby Laboratories’s results here and Agilysys’s results here.
The euphoria surrounding Trump’s November win lit a fire under major indices, but potential tariffs have caused the market to do a 180 in 2025. Investors in vertical software stocks have been spared in this environment as share prices are down 17.8% on average over the last month. Doximity is down 23.4% during the same time and is heading into earnings with an average analyst price target of $63 (compared to the current share price of $34.93).
Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
